Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Henry Chambers MD

Henry F Chambers MD

Professor of Medicine, Director of Clinical Research Services of the Clinical and Translational Science Institute, University of California, San Francisco School of Medicine, San Francisco, CA

Dr. Chambers graduated from Vanderbilt University School of Medicine in 1977 where he was class valedictorian. He trained in Internal Medicine and Infectious Diseases at the University of California San Francisco. He was also a Kaiser Foundation Fellow in General Internal Medicine at UCSF and a post-doctoral research fellow at Rockefeller University. Dr. Chambers is Professor of Medicine and Director of Clinical Research Services for the UCSF Clinical Translational Science Institute. He served as Chief of Infectious Diseases at San Francisco General Hospital from 1992-2013 and Director of the UCSF Infectious Diseases Fellowship Training Program from 2002-2013. He is a Fellow of the Infectious Diseases Society of America (IDSA) and of the American College of Physicians and was elected to membership in the American Society of Clinical Investigation and the American Association of Physicians. He is editor for the Sanford Guide to Antimicrobial Therapy and he has over 200 original publications and textbook chapters in the areas of drug resistance, endocarditis, bacterial infections, and staphylococcal diseases.  

He is an editor for Antimicrobial Agents and Chemotherapy and a reviewer for numerous medical publications. He has been a member of advisory groups for the Centers for Diseases Control and Prevention, a member of the IDSA treatment guidelines committee for skin and soft tissue infections, and co-chaired the IDSA guidelines committee for treatment of methicillin-resistant Staphylococcus aureus infections. He chairs the Antimicrobial Resistance Committee of IDSA. He and Dr. Vance Fowler are Co-Principal Investigators of the Antibacterial Resistance Leasdership Group. His clinical and research interests are antimicrobial drug resistance, staphylococcal infections, experimental therapeutics, and epidemiology and pathogenesis of disease caused by community methicillin-resistant Staphylococcus aureus.

Recent Contributions to PracticeUpdate:

  1. AHA Statement on Infective Endocarditis in Adults